BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24716838)

  • 21. Isocitrate Dehydrogenase 2 Suppresses the Invasion of Hepatocellular Carcinoma Cells via Matrix Metalloproteinase 9.
    Tian GY; Zang SF; Wang L; Luo Y; Shi JP; Lou GQ
    Cell Physiol Biochem; 2015; 37(6):2405-14. PubMed ID: 26646705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
    Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
    Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy.
    Wu SJ; Zhang ZZ; Cheng NS; Xiong XZ; Yang L
    Surg Oncol; 2019 Jun; 29():159-167. PubMed ID: 31196483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC.
    Xu B; Cai Z; Zeng Y; Chen L; Du X; Huang A; Liu X; Liu J
    J Clin Pathol; 2014 Nov; 67(11):974-9. PubMed ID: 25092674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.
    Wang WL; Zheng XL; Zhang ZY; Zhou Y; Hao J; Tang G; Li O; Xiang JX; Wu Z; Wang B
    Medicine (Baltimore); 2016 Jul; 95(27):e4087. PubMed ID: 27399101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis.
    Kim J; Hong SJ; Park JH; Park SY; Kim SW; Cho EY; Do IG; Joh JW; Kim DS
    Oncol Rep; 2009 Jun; 21(6):1449-54. PubMed ID: 19424622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(4):1207-15. PubMed ID: 25632194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.
    Zhang H; Yuan SX; Dai SY; Zhang JM; Huang X; Lu CD; Lu JH; Wu FQ; Lau WY; Wu MC; Yang T; Shen F
    World J Surg; 2014 Apr; 38(4):947-57. PubMed ID: 24258262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
    Kim SH; Ahn S; Park CK
    Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance and function of
    Chen YR; Li YT; Wang MQ; Zhu SL
    Future Oncol; 2021 Nov; 17(33):4457-4470. PubMed ID: 34350781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
    Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
    Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.